title: Nocloprost, a novel prostanglandin E2 analog: significant reduction of aspirin induced grastrointestinal lesions in man.
authors.affiliation: Krankenhaus Bethanien, Hamburg, F.R.G.
authors.forename: H G
authors.initials: HG
authors.lastname: Dammann
authors.forename: M
authors.initials: M
authors.lastname: Dreyer
authors.forename: T A
authors.initials: TA
authors.lastname: Walter
authors.forename: P
authors.initials: P
authors.lastname: Müller
authors.forename: B
authors.initials: B
authors.lastname: Simon
authors.forename: R W
authors.initials: RW
authors.lastname: Wabnitz
mesh_terms: D000328:Adult; D001241:Aspirin / Q000009:adverse effects*; D002986:Clinical Trials as Topic; D004311:Double-Blind Method; D004386:Duodenum / Q000187:drug effects / Q000473:pathology; D005753:Gastric Mucosa / Q000187:drug effects / Q000473:pathology*; D006801:Humans; D007413:Intestinal Mucosa / Q000187:drug effects / Q000473:pathology*; D008297:Male; D011461:Prostaglandins F, Synthetic / Q000627:therapeutic use*
chemical_list: D011461:Prostaglandins F, Synthetic; C048895:nocloprost; D001241:Aspirin